VSM gets backing for brain MEG (magnetoencephalography) system:
This article was originally published in Clinica
Executive Summary
VSM MedTech, the Vancouver, Canada-based developer of non-invasive magnetoencephalography (MEG) functional brain imaging systems, is to receive Can$350,000 ($304, 862) grant from the Canadian government. The funding, which will be provided on a cost-incurred basis during 2006, will go towards the Can$1.5m electronics redesign initiative that the company has undertaken to improve its CTF MEG systems. The redesign will enable VSM to produce the systems more cheaply without compromising on the product's performance, said the company. It added that the reduced manufacturing costs would improve gross margins and increase the firm's likelihood of breaking even in 2007.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.